| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.27 | 0.009 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |